These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 12891190
1. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). Andersen HR, Nielsen TT, Vesterlund T, Grande P, Abildgaard U, Thayssen P, Pedersen F, Mortensen LS, DANAMI-2 Investigators. Am Heart J; 2003 Aug; 146(2):234-41. PubMed ID: 12891190 [Abstract] [Full Text] [Related]
2. The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up. Busk M, Maeng M, Rasmussen K, Kelbaek H, Thayssen P, Abildgaard U, Vigholt E, Mortensen LS, Thuesen L, Kristensen SD, Nielsen TT, Andersen HR, DANAMI-2 Investigators. Eur Heart J; 2008 May; 29(10):1259-66. PubMed ID: 17956874 [Abstract] [Full Text] [Related]
7. [Angioplasty or fibrinolytic therapy in acute myocardial infarction with ST elevation?]. Vik-Mo H. Tidsskr Nor Laegeforen; 2004 Mar 04; 124(5):648-51. PubMed ID: 15004611 [Abstract] [Full Text] [Related]
8. Long-term outcome of primary angioplasty compared with fibrinolysis across age groups: a Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) substudy. Fosbøl EL, Thune JJ, Kelbaek H, Andersen HR, Saunamäki K, Nielsen TT, Mortensen LS, Køber L, DANAMI-2 Investigators. Am Heart J; 2008 Aug 04; 156(2):391-6. PubMed ID: 18657676 [Abstract] [Full Text] [Related]
9. Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). Cantor WJ, Fitchett D, Borgundvaag B, Heffernan M, Cohen EA, Morrison LJ, Ducas J, Langer A, Mehta S, Lazzam C, Schwartz B, Dzavik V, Goodman SG. Am Heart J; 2008 Jan 04; 155(1):19-25. PubMed ID: 18082484 [Abstract] [Full Text] [Related]
11. [The early management of ST-elevation acute myocardial infarction in the Lombardy Region (GestIMA)]. Oltrona L, Mafrici A, Marzegalli M, Fiorentini C, Pirola R, Vincenti A, Studio GestIMA e della Sezione Regionale Lombarda dell'ANMCO e della SIC. Ital Heart J Suppl; 2005 Aug 04; 6(8):489-97. PubMed ID: 16161503 [Abstract] [Full Text] [Related]
12. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Circulation; 2003 Oct 14; 108(15):1809-14. PubMed ID: 14530206 [Abstract] [Full Text] [Related]
13. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results. Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ. Kardiol Pol; 2006 Aug 14; 64(8):793-9; discussion 800-1. PubMed ID: 16981054 [Abstract] [Full Text] [Related]
18. Which strategy should be used for acute ST-elevation myocardial infarction in patients aged more than 75 years? La Manna A, Goktekin O, Fiscella D, Dalby M, Tanigawa J, Fiscella A, Tamburino C, Di Mario C. J Cardiovasc Med (Hagerstown); 2006 Jun 14; 7(6):388-96. PubMed ID: 16721199 [Abstract] [Full Text] [Related]
19. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, Gulba DC, Kracoff OH, Lewis BS, Roguin N, Antman EM, Braunwald E, ExTRACT-TIMI 25 Investigators. J Am Coll Cardiol; 2007 Jun 12; 49(23):2238-46. PubMed ID: 17560287 [Abstract] [Full Text] [Related]
20. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals. Dobrzycki S, Kralisz P, Nowak K, Prokopczuk P, Kochman W, Korecki J, Poniatowski B, Zuk J, Sitniewska E, Bachorzewska-Gajewska H, Sienkiewicz J, Musial WJ. Eur Heart J; 2007 Oct 12; 28(20):2438-48. PubMed ID: 17884846 [Abstract] [Full Text] [Related] Page: [Next] [New Search]